Literature DB >> 22560295

Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy.

Rajat J Kudchadker1, Thomas J Pugh, David A Swanson, Teresa L Bruno, Yasemin Bolukbasi, Steven J Frank.   

Abstract

Advances in brachytherapy treatment planning systems have allowed the opportunity for brachytherapy to be planned intraoperatively as well as preoperatively. The relative advantages and disadvantages of each approach have been the subject of extensive debate, and some contend that the intraoperative approach is vital to the delivery of optimal therapy. The purpose of this study was to determine whether high-quality permanent prostate implants can be achieved consistently using a preoperative planning approach that allows for, but does not necessitate, intraoperative optimization. To achieve this purpose, we reviewed the records of 100 men with intermediate-risk prostate cancer who had been prospectively treated with brachytherapy monotherapy between 2006 and 2009 at our institution. All patients were treated with iodine-125 stranded seeds; the planned target dose was 145 Gy. Only 8 patients required adjustments to the plan on the basis of intraoperative findings. Consistency and quality were assessed by calculating the correlation coefficient between the planned and implanted amounts of radioactivity and by examining the mean values of the dosimetric parameters obtained on preoperative and 30 days postoperative treatment planning. The amount of radioactivity implanted was essentially identical to that planned (mean planned radioactivity, 41.27 U vs. mean delivered radioactivity, 41.36 U; R(2) = 0.99). The mean planned and day 30 prostate V100 values were 99.9% and 98.6%, respectively. The mean planned and day 30 prostate D90 values were 186.3 and 185.1 Gy, respectively. Consistent, high-quality prostate brachytherapy treatment plans can be achieved using a preoperative planning approach, mostly without the need for intraoperative optimization. Good quality assurance measures during simulation, treatment planning, implantation, and postimplant evaluation are paramount for achieving a high level of quality and consistency.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22560295      PMCID: PMC3935513          DOI: 10.1016/j.meddos.2012.03.001

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  20 in total

1.  Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy.

Authors:  Michael J Zelefsky; Yoshiya Yamada; Christine Marion; Sang Sim; Gilad Cohen; Leah Ben-Porat; David Silvern; Marco Zaider
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-15       Impact factor: 7.038

2.  Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.

Authors:  Nelson N Stone; Suzanne Hong; Yeh-Chi Lo; Victor Howard; Richard G Stock
Journal:  Brachytherapy       Date:  2003       Impact factor: 2.362

Review 3.  Low-dose-rate brachytherapy for prostate cancer: preplanning vs. intraoperative planning-preplanning is best.

Authors:  John C Blasko
Journal:  Brachytherapy       Date:  2006 Jul-Sep       Impact factor: 2.362

4.  A dose-response study for I-125 prostate implants.

Authors:  R G Stock; N N Stone; A Tabert; C Iannuzzi; J K DeWyngaert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-04-01       Impact factor: 7.038

5.  Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)?

Authors:  Michael A Papagikos; Allan F Deguzman; Peter J Rossi; David L McCullough; Peter E Clark; W Robert Lee
Journal:  Brachytherapy       Date:  2005       Impact factor: 2.362

6.  Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.

Authors:  G S Merrick; W M Butler; A T Dorsey; J H Lief
Journal:  Tech Urol       Date:  2001-09

7.  Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.

Authors:  Tracy Sherertz; Kent Wallner; Gregory Merrick; Eric Ford; Steven Sutlief; William Cavanagh; Wayne Butler; Lawrence True
Journal:  Brachytherapy       Date:  2004       Impact factor: 2.362

Review 8.  Update on brachytherapy in localized prostate cancer: the importance of dosimetry.

Authors:  James J Urbanic; W Robert Lee
Journal:  Curr Opin Urol       Date:  2006-05       Impact factor: 2.309

9.  Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current technique.

Authors:  Peter D Grimm; John C Blasko; John E Sylvester; Charles Heaney; James Gasparich; Jeffrey Quackenbush; Jim Gottesman; Jim Downey; Doug Grier; Tim Roddy; Roger Nellans; Narender Sood; David Wahl
Journal:  Brachytherapy       Date:  2004       Impact factor: 2.362

10.  Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.

Authors:  Louis Potters; Eric A Klein; Michael W Kattan; Chandana A Reddy; Jay P Ciezki; Alwyn M Reuther; Patrick A Kupelian
Journal:  Radiother Oncol       Date:  2004-04       Impact factor: 6.280

View more
  4 in total

1.  Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Authors:  Nikhil G Thaker; Thomas J Pugh; Usama Mahmood; Seungtaek Choi; Tracy E Spinks; Neil E Martin; Terence T Sio; Rajat J Kudchadker; Robert S Kaplan; Deborah A Kuban; David A Swanson; Peter F Orio; Michael J Zelefsky; Brett W Cox; Louis Potters; Thomas A Buchholz; Thomas W Feeley; Steven J Frank
Journal:  Brachytherapy       Date:  2016-02-23       Impact factor: 2.362

2.  Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.

Authors:  T Shaikh; N G Zaorsky; K Ruth; D Y Chen; R E Greenberg; J Li; K Crawford; E M Horwitz
Journal:  Brachytherapy       Date:  2014-11-07       Impact factor: 2.362

3.  Intra-operative 3D hologram support with mixed reality technique based on CT-MRI fusion images: operation guidance for brain brachytherapy.

Authors:  Shifeng Liu; Hong Wang; Congxiao Wang; Wei Zhang; Gao Chen; Xiaokun Hu
Journal:  J Contemp Brachytherapy       Date:  2021-04-14

4.  Dosimetric outcomes of preoperative treatment planning with intraoperative optimization using stranded seeds in prostate brachytherapy.

Authors:  Jason Joon Bock Lee; Eungman Lee; Won Hoon Choi; Jihun Kim; Kyung Hwan Chang; Dong Wook Kim; Han Back Shin; Tae Hyung Kim; Hwa Kyung Byun; Jaeho Cho
Journal:  PLoS One       Date:  2022-03-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.